Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1991 Sep;35(9):1710–1716. doi: 10.1128/aac.35.9.1710

Pharmacodynamics of daptomycin and vancomycin on Enterococcus faecalis and Staphylococcus aureus demonstrated by studies of initial killing and postantibiotic effect and influence of Ca2+ and albumin on these drugs.

H Hanberger 1, L E Nilsson 1, R Maller 1, B Isaksson 1
PMCID: PMC245255  PMID: 1659305

Abstract

The pharmacodynamics of daptomycin and vancomycin on Enterococcus faecalis ATCC 29212 and Staphylococcus aureus ATCC 25923 were investigated by studying the postantibiotic effect (PAE) and initial killing. The influence of Ca2+ and albumin on these drugs was also evaluated. The PAE was studied by use of bioluminescence assay of bacterial ATP. Daptomycin at clinically achievable concentrations produced a dose-dependent PAE on E. faecalis (0.6 to 6.7 h) and S. aureus (1.0 to 6.3 h). The long PAE of daptomycin was seen simultaneously with a potent dose-dependent initial killing assayed by viable count determination. The initial change in bacterial ATP was not as extensive as the decrease in viability. Vancomycin at corresponding concentrations produced shorter PAEs on E. faecalis (0.5 to 1.0 h) and S. aureus (1.3 to 1.8 h). This coincides with a weak non-dose-dependent initial change in viability and intracellular ATP. The MICs of vancomycin were not influenced by different Ca2+ concentrations or by the addition of albumin to the broth. The MICs of daptomycin for both strains were lowered, and the PAEs were prolonged with increasing concentrations of Ca2+ in the broth. The PAE of daptomycin was Ca2+ dependent to the same extent as the MIC was. In the presence of physiological concentrations of albumin and free Ca2+, the PAEs of daptomycin on both strains were reduced and the MICs were increased in comparison with the results obtained in pure Mueller-Hinton broth with approximately the same free Ca2+ concentration. This decrease in daptomycin activity was considered to be due to the albumin binding of daptomycin. Despite the albumin binding of daptomycin, the PAE produced on E. faecalis and S. aureus in the presence of a physiological free Ca2+ concentration was still over 6 h at clinically achievable concentrations.

Full text

PDF
1710

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrew J. H., Wale M. C., Wale L. J., Greenwood D. The effect of cultural conditions on the activity of LY146032 against staphylococci and streptococci. J Antimicrob Chemother. 1987 Aug;20(2):213–221. doi: 10.1093/jac/20.2.213. [DOI] [PubMed] [Google Scholar]
  2. Benson C. A., Beaudette F., Trenholm G. Comparative in-vitro activity of LY146032 a new peptolide, with vancomycin and eight other agents against gram-positive organisms. J Antimicrob Chemother. 1987 Aug;20(2):191–196. doi: 10.1093/jac/20.2.191. [DOI] [PubMed] [Google Scholar]
  3. Bush L. M., Boscia J. A., Kaye D. Daptomycin (LY146032) treatment of experimental enterococcal endocarditis. Antimicrob Agents Chemother. 1988 Jun;32(6):877–881. doi: 10.1128/aac.32.6.877. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bush L. M., Boscia J. A., Wendeler M., Pitsakis P. G., Kaye D. In vitro postantibiotic effect of daptomycin (LY146032) against Enterococcus faecalis and methicillin-susceptible and methicillin-resistant Staphylococcus aureus strains. Antimicrob Agents Chemother. 1989 Aug;33(8):1198–1200. doi: 10.1128/aac.33.8.1198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Calain P., Krause K. H., Vaudaux P., Auckenthaler R., Lew D., Waldvogel F., Hirschel B. Early termination of a prospective, randomized trial comparing teicoplanin and flucloxacillin for treating severe staphylococcal infections. J Infect Dis. 1987 Feb;155(2):187–191. doi: 10.1093/infdis/155.2.187. [DOI] [PubMed] [Google Scholar]
  6. Drusano G. L. Role of pharmacokinetics in the outcome of infections. Antimicrob Agents Chemother. 1988 Mar;32(3):289–297. doi: 10.1128/aac.32.3.289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Eliopoulos G. M., Thauvin C., Gerson B., Moellering R. C., Jr In vitro activity and mechanism of action of A21978C1, a novel cyclic lipopeptide antibiotic. Antimicrob Agents Chemother. 1985 Mar;27(3):357–362. doi: 10.1128/aac.27.3.357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fass R. J., Helsel V. L. In vitro activity of LY146032 against staphylococci, streptococci, and enterococci. Antimicrob Agents Chemother. 1986 Nov;30(5):781–784. doi: 10.1128/aac.30.5.781. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Garrison M. W., Vance-Bryan K., Larson T. A., Toscano J. P., Rotschafer J. C. Assessment of effects of protein binding on daptomycin and vancomycin killing of Staphylococcus aureus by using an in vitro pharmacodynamic model. Antimicrob Agents Chemother. 1990 Oct;34(10):1925–1931. doi: 10.1128/aac.34.10.1925. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hanberger H., Nilsson L. E., Kihlström E., Maller R. Postantibiotic effect of beta-lactam antibiotics on Escherichia coli evaluated by bioluminescence assay of bacterial ATP. Antimicrob Agents Chemother. 1990 Jan;34(1):102–106. doi: 10.1128/aac.34.1.102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Isaksson B., Nilsson L., Maller R., Sörén L. Postantibiotic effect of aminoglycosides on gram-negative bacteria evaluated by a new method. J Antimicrob Chemother. 1988 Jul;22(1):23–33. doi: 10.1093/jac/22.1.23. [DOI] [PubMed] [Google Scholar]
  12. Kobayashi H., Van Brunt J., Harold F. M. ATP-linked calcium transport in cells and membrane vesicles of Streptococcus faecalis. J Biol Chem. 1978 Apr 10;253(7):2085–2092. [PubMed] [Google Scholar]
  13. Krogstad D. J., Moellering R. C., Jr, Greenblatt D. J. Single-dose kinetics of intravenous vancomycin. J Clin Pharmacol. 1980 Apr;20(4 Pt 1):197–201. doi: 10.1002/j.1552-4604.1980.tb01696.x. [DOI] [PubMed] [Google Scholar]
  14. Larsson L., Finnström O., Nilsson B., Ohman S. Evaluation of radiometer ICA1 as a routine instrument for serum ionized calcium and its application for whole blood capillary samples from newborn infants. Scand J Clin Lab Invest Suppl. 1983;165:21–26. [PubMed] [Google Scholar]
  15. McCarthy L. R., Senne J. E. Evaluation of acridine orange stain for detection of microorganisms in blood cultures. J Clin Microbiol. 1980 Mar;11(3):281–285. doi: 10.1128/jcm.11.3.281-285.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Nilsson L., Sörén L. Selective growth of resistant variants during incubation of Enterobacteriaceae with four aminoglycosides. J Antimicrob Chemother. 1986 Sep;18(3):317–324. doi: 10.1093/jac/18.3.317. [DOI] [PubMed] [Google Scholar]
  17. Odenholt I., Isaksson B., Nilsson L., Cars O. Postantibiotic and bactericidal effect of imipenem against Pseudomonas aeruginosa. Eur J Clin Microbiol Infect Dis. 1989 Feb;8(2):136–141. doi: 10.1007/BF01963897. [DOI] [PubMed] [Google Scholar]
  18. Parenti F. Glycopeptide antibiotics. J Clin Pharmacol. 1988 Feb;28(2):136–140. doi: 10.1002/j.1552-4604.1988.tb05737.x. [DOI] [PubMed] [Google Scholar]
  19. Silva M., Jacobus N. V., Gorbach S. L. In vitro activity of LY146032 against gram-positive bacteria. Diagn Microbiol Infect Dis. 1988 Feb;9(2):79–85. doi: 10.1016/0732-8893(88)90100-9. [DOI] [PubMed] [Google Scholar]
  20. Stratton C. W., Liu C., Ratner H. B., Weeks L. S. Bactericidal activity of deptomycin (LY146032) compared with those of ciprofloxacin, vancomycin, and ampicillin against enterococci as determined by kill-kinetic studies. Antimicrob Agents Chemother. 1987 Jul;31(7):1014–1016. doi: 10.1128/aac.31.7.1014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Stratton C. W., Weeks L. S. Effect of human serum on the bactericidal activity of daptomycin and vancomycin against staphylococcal and enterococcal isolates as determined by time-kill kinetic studies. Diagn Microbiol Infect Dis. 1990 May-Jun;13(3):245–252. doi: 10.1016/0732-8893(90)90067-6. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES